Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruilin Xiong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Ha Jason

    Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia

    1 shared publication
  • Kang Ning

    State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

    1 shared publication
  • Mingguang He

    School of Optometry, The Hong Kong Polytechnic University, Hong Kong SAR, China

    1 shared publication
  • Wei Wang

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Xiaotong Han

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, China

    1 shared publication
  • Ye Xie

    Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China

    1 shared publication

Latest Publications

  • Open Access

    The Mediterranean Diet and Age-Related Eye Diseases: A Systematic Review

    by Yi Wu, Ye Xie, Yixiong Yuan, Ruilin Xiong, Yuxin Hu, Kang Ning, Jason Ha, Wei Wang, Xiaotong Han, Mingguang He

    The Mediterranean diet (MD) is a healthy diet pattern that can prevent chronic age-related diseases, especially age-related eye diseases (AREDs) including cataract, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR) and dry eye syndrome (DES). In this study, we systematically reviewed studies in the literature that had reported associations between adherence to the MD and the five above-mentioned AREDs. Randomized controlled trials as well as prospective and retrospective observational studies were included; 1164 studies were identified, of which 1, 2, 9, 2 and 4 studies met our eligibility criteria for cataract, glaucoma, AMD, DR, and DES, respectively. According to these studies, higher MD adherence was associated with reduced risks of incident DR, incident AMD and progression to late AMD, but whether early and neovascular AMD could be alleviated remained to be debated. The results regarding the effects of the MD on DES were mixed, with three studies reporting an associations between MD and decreased severity or incidence of DES, whereas one study reported the opposite. No significant associations were observed between the MD and cataract or glaucoma. Generally, convincing evidence suggested a protective effect of the MD against AMD and DR. However, the evidence for cataract, glaucoma, and DES was less conclusive, and high-quality studies are needed for comprehensive evaluations of the potential benefits of MD on these eye diseases.